I
IMMUNOVANT INC
NASDAQ: IMVT (Immunovant, Inc.)
Last update: 10 hours ago14.69
-0.13 (-0.88%)
| Previous Close | 14.82 |
| Open | 14.82 |
| Volume | 780,218 |
| Avg. Volume (3M) | 1,284,769 |
| Market Cap | 2,560,716,544 |
| Price / Book | 4.27 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Diluted EPS (TTM) | -2.73 |
| Total Debt/Equity (MRQ) | 0.01% |
| Current Ratio (MRQ) | 11.16 |
| Operating Cash Flow (TTM) | -375.87 M |
| Levered Free Cash Flow (TTM) | -227.82 M |
| Return on Assets (TTM) | -37.97% |
| Return on Equity (TTM) | -62.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Immunovant, Inc. | Bullish | Bearish |
AIStockmoo Score
1.4
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 1.38 |
|
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn). |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 58.17% |
| % Held by Institutions | 55.78% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Alpine Global Management, Llc | 30 Jun 2025 | 2,626,692 |
| Two Seas Capital Lp | 30 Jun 2025 | 2,252,772 |
| Perceptive Advisors Llc | 30 Jun 2025 | 2,137,890 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 37.00 (JP Morgan, 151.87%) | Buy |
| Median | 30.00 (104.22%) | |
| Low | 18.00 (UBS, 22.53%) | Hold |
| Average | 28.33 (92.85%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 15.73 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B of A Securities | 12 Aug 2025 | 30.00 (104.22%) | Buy | 15.21 |
| JP Morgan | 12 Aug 2025 | 37.00 (151.87%) | Buy | 15.21 |
| UBS | 28 Jul 2025 | 18.00 (22.53%) | Hold | 16.76 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |